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Abstract
Aim The purpose of this is to evaluate the safety and feasibil-
ity of recrossing the interatrial septum in case of inadvertent
loss of or need for repeated left atrial access using a simple
electroanatomical landmark without the use of fluoroscopy.
Methods Twenty-five consecutive patients undergoing pul-
monary vein isolation (PVI) for paroxysmal (n=12) or persis-
tent (n=13) atrial fibrillation ablation were included. All pro-
cedures were performed using an electroanatomical mapping
system (Carto 3, Biosense Webster, Diamond Bar, USA).
After fluoroscopy-guided double transseptal puncture and fast
anatomical mapping of the left atrium, a reconstruction of the
transseptal access was created by retracting the mapping cath-
eter into the sheath to the level of the inferior vena cava. After
completing the left sided ablation, both sheaths and catheters
were withdrawn to the inferior vena cava. Recrossing was
then attempted by fellows (EF) and experienced operators
(EO) using the reconstruction of the transseptal access in a
standard right anterior oblique (RAO) and left anterior oblique
(LAO) projection without the use of fluoroscopy.
Results Using the described technique, EP fellows and expe-
rienced operators could recross the interatrial septum without
fluoroscopy in all patients. Median time needed for recrossing
was 14 s (interquartile range (IQR) 7–20). Median recrossing
times did not differ significantly between EF and EO (14 (IQR
8–26.5 s) versus 12 (IQR 6.5–17.5 s), p=0.26). In five (20 %)
procedures, recrossing was necessary during the procedure
after intermittent mapping of the right atrium or inadvertent
catheter dislodgment.
Conclusion Adding a simple and fast anatomical reconstruc-
tion of the transseptal access to the standard left atrial mapping
procedure allows for easy and fluoroscopy-free recrossing of
the interatrial septum during atrial fibrillation ablation and
further reduces radiation exposure.
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Abbreviations
AF Atrial fibrillation
BMI Body mass index
EF Electrophysiology fellow
EO Experienced operator
IQR Interquartile range
LA Left atrium
PVI Pulmonary vein isolation
PFO Patent foramen ovale
TSP Transseptal puncture
1 Introduction
In the last decade, pulmonary vein isolation (PVI) emerged as
a therapy for many patients with atrial fibrillation (AF). Since
then, the number of PVIs increased substantially not least due
to development of electroanatomic mapping (EAM) systems
[1]. However, fluoroscopy is still used for performing
transseptal punctures (TSP), catheter placement, and handling
of the sheaths [2]. Use of the fluoroscopy exposes the opera-
tors, the nurses, and the patients to ionizing radiation. Efforts
have been made to reduce radiation exposure to the patients
and the electrophysiology staff. Today, using contemporary
EAM systems, pulmonary vein isolation can be performed
with low doses of fluoroscopy. Standard, fluoroscopy-guided
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transseptal puncture is performed in the majority of cases [3].
However, echocardiographic (intracardiac or transesophageal
echocardiography) are being used to increase patient safety
and reduce fluoroscopy exposure [4, 5]. Also, in the PVI era,
advances in electroanatomical mapping systems have dramat-
ically reduced fluoroscopy times during the TSP and PVI. In
experienced hands, fluoroscopy today is needed almost only
for the initial transseptal puncture. However, inadvertent loss
of left atrial access during the ablation procedures can occur
and regaining access can be time-consuming and increase the
radiation exposure to the patient and the operator.
Furthermore, during persistent AF ablation, mapping and
ablation in the right atrium might be needed [6, 7]. In some
cases, after right atrial ablation, new left atrial access is needed
to complete the ablation.
We sought to evaluate the feasibility and safety of
recrossing the interatrial septum using a simple
electroanatomical landmark without the use of fluoroscopy.
2 Methods
2.1 Study population
The study population consisted of 25 consecutive patients
undergoing PVI. Indications for PVI were according to cur-
rent ESC and EHRA guidelines for atrial fibrillation [8]. We
included patients undergoing PVI for paroxysmal and persis-
tent AF. Written informed consent was obtained for PVI in all
patients.
2.2 Preprocedural management
All patients provided informed consent before the procedure.
Atrial fibrillation was verified in a 12-lead ECG in all patients.
All subjects underwent transesophageal echocardiography to
rule out left atrial thrombus the day before the procedure. Left
atrial anatomy was assessed in all patients using cardiac
magnetic resonance imaging or computed tomography prior
to the procedure. Oral anticoagulation was not interrupted for
the procedure in patients on vitamin K antagonists. In patients
on dabigatran, the last dose was given 24 h before the
procedure.
2.3 Transseptal puncture
After obtaining vascular access in the right groin, one short
(8 F) and two long sheaths (SL1, 8.5 F, St. JudeMedical, MN,
USA) were placed over the long, J tip wires placed in the
superior vena cava. After vascular access, 2500 IU of heparin
were administered. The ablation catheter (Thermocool SF or
SmartTouch, Biosense Webster, USA) was then positioned
through the short sheath in the coronary sinus in order to serve
as a landmark for TSP. TSP was performed according to our
standard protocol. Using biplane fluoroscopy, two transseptal
punctures were made with the use of contrast injection and
pressure monitoring from the tip of the needle. Once the
puncture was made, the 0.032 F J tip wire was advanced into
one of the left pulmonary veins and the whole system was
advanced over the wire. For the purpose of this study, each
transseptal puncture was then categorized according to diffi-
culty as easy, medium, or difficult. If TSP was successful with
the first attempt, with no need for repositioning of the sheaths
or a repeated pulldown and it was easy to get across with the
sheath, it was categorized as easy. If there was a need for a
repeated pulldown and repositioning or there were difficulties
with advancing the system across the septum, the puncture
was categorized as medium difficult. If both repositioning or
repeated pulldown maneuvers were needed together with
difficulties in advancing the system across the septum, the
puncture was termed difficult. After the successful TSP, hep-
arin was administered to achieve an activated clotting time
(ACT) >350 s. The ACTwas checked every 20min during the
whole procedure.
2.4 Electroanatomical mapping
After left atrial access, fast anatomical mapping (FAM) of the
left atrium (LA) was performed using the EAM system. The
LA reconstruction from the cardiac MRI was used as guid-
ance. FAM was performed using a 20 electrode variable
circular mapping catheter (Lasso Nav, Biosense Webster,
Diamond Bar, CA, USA) with additional FAM reconstruction
with the ablation catheter if needed. After completion of the
LA map, additional anatomical mapping of the transseptal
access site was created. While assuring that the transseptal
sheath was in the LA, the ablation catheter was retracted to the
level of the inferior vena cava to mark the direction of the TSP
and the sheath ((Fig. 1a) showing right anterior oblique
(RAO) and left anterior oblique (LAO) views with superior
tilt on the CARTO map). The procedure of mapping the TSP
site added less than 1 min to the standard PVI procedure in all
cases.
2.5 Pulmonary vein isolation
PVI was then performed with the standard protocol using the
3.5-mm irrigated-tip ablation catheter (ThermoCool SF,
SmartTouch, Biosense Webster, Diamond Bar, CA, USA)
with power set at 25 to 30 W and flow rate of 17 mL/min.
Ablation was performed with continuous, encircling lesions in
an antral manner. Electrical isolation was confirmed with the
20 pole circular mapping catheter by verifying entrance and/or
exit block in all PVs.
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2.6 Recrossing the interatrial septum
Once the veins were isolated, transseptal sheaths and catheters
were pulled back from the LA to the inferior vena cava. At that
time, recrossing the interatrial septum with the ablation catheter
was attempted by the senior, experienced operator (EO) and by
the electrophysiology fellow (EF). Recrossing was done with-
out the use of fluoroscopy, only with the guidance of the
previously recorded “transseptal sleeve” on the FAM.
Standard right anterior oblique (RAO) 30° and left anterior
oblique (LAO) 45° projections were used on EAM (Fig. 1).
Both, successful recrossing and time to recross were recorded.
During some of the PVI procedures, recrossing was also
attempted using the same method due to catheter dislodgement
to the right atrium or mapping in the right atrium. In these cases,
recrossing was performed using the above-described method,
but only success rate was recorded, without timing.
2.7 Postprocedural management
After sheath removal, all patients were monitored overnight.
Transthoracic echocardiography was performed after the pro-
cedure to rule out pericardial effusion. Oral anticoagulation
was continued after the procedure for at least 3 months and
after that according to CHA2DS2VASC score criteria.
Patients were discharged at the first postoperative day if no
complications occurred.
2.8 Statistical analysis
Continuous variables are presented as mean±one standard
deviation or as median and interquartile range (IQR) in case
of skewed distribution. For continuous variables, comparisons
were made using Student’s t-test, or Mann-Whitney U test, as
appropriate. A one-way ANOVA with Tukey’s post hoc test
was used for comparisons between multiple groups. A p value
<0.05 was considered to indicate statistical significance.
Calculations were made using GraphPad Prism (5.0a).
3 Results
3.1 Study population
A total of 25 patients (mean age of 58±7 years, 76%men, left
atrial size in the parasternal long axis 41±6 mm, mean left
ventricular ejection fraction 54±6 %) were studied.
Twelve patients (48 %) underwent PVI for paroxysmal
atrial fibrillation and 13 (52 %) for persistent AF. Median
duration of AF was 24 months (IQR 14.8–50.3). Baseline
clinical characteristics of patients are shown in Table 1.
3.2 Procedural data
In all patients PVI was performed using the 3.5-mm irrigated
tip catheter (Thermocool SF, BiosenseWebster, Diamond Bar,
CA, USA). Acute pulmonary vein isolation was achieved in
all patients. Median procedure duration and mean ablation
duration were 124 min (IQR 103–151) and 1721.6±829.9 s
respectively. Mean fluoroscopy time was 8.9±6.7 min and
median fluoroscopy doses (dose area product) was
1245 μGym2 (IQR 659–1939), respect ively. No
periprocedural complications occurred.
3.3 Recrossing of the interatrial septum
Recrossing of the interatrial septum was successfully per-
formed both by electrophysiology fellows and experienced
operators in all procedures in median 14 s (IQR 7–20).
Median recrossing times did not differ significantly between
Fig. 1 RAO view is shown on the left and LAO viewwith superior tilt on
the right. a–c Recrossing of the interatrial septum with catheter positions
in inferior vena cava (a), at the interatrial septum (b), and in the left atrium
after recrossing (c)
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easy TSP group and medium/difficult TSP group (Table 2).
Since there was a small number of TSPs that were classified as
medium or difficult, they were analyzed as a single group.
Median times to recross the septum did not differ significantly
between EF and EO (14 s (IQR 8.0–26.5) versus 12 s (IQR
6.5–17.5), p=0.26). Procedural data and results of recrossing
the interatrial septum using this method are shown in Table 2.
In five patients (20 %), catheter displacement into the right
atrium occurred during the PVI procedure and in all five cases
recrossing was successfully performed using the EAM of the
TSP without fluoroscopy.
4 Discussion
This study shows that recrossing the interatrial septum using an
anatomical map of the transseptal puncture is safe, feasible, and
can be learned easily. Recrossing using this method was
achieved in a median of 14 s (IQR 7–20) and was successfully
performed both by experienced operators and fellows. Marking
the FAM of the TSP after the creation of the FAM of the LA
adds less than 1 min to the procedure, and it can later serve as a
marker for recrossing the interatrial septum in case of catheter
dislodgement to the right atrium or after right atrial mapping.
This not only potentially reduces procedure times but more
importantly reduces fluoroscopy times during PVI. To our
knowledge, this is the first prospective evaluation of feasibility
of fluoroscopy-free manual recrossing of the interatrial septum
with the use of electroanatomic mapping system.
Although fluoroscopy still remains indispensable for most
of the electrophysiology procedures, especially when TSP is
involved, efforts have been made to reduce radiation exposure
to patients and operators. Radiation exposure has potential
detrimental health effects on both operators and patients both
through stochastic effects (including malignancy) and deter-
ministic effects (skin erythema, cataracts) [9]. Applying the
ALARA concept (“As low as reasonably achievable”) in a
daily practice is recommended by most cardiology and radi-
ology societies [9, 10].
The technique we used can be considered as a modification
and advance of that described by Yamada et al. [11] with a
one-puncture, double-transseptal catheterization maneuver. In
their report, they performed a single TSP, and while leaving a
guide wire across the interatrial septum in the left-sided PVs,
crossed the septumwith the mapping catheter beside the guide
wire. While the approach described by Yamada et al. used
fluoroscopy and a wire left in the LA as a landmark, our
approach is completely fluoroscopy-free and uses an anatom-
ical map to guide access to the LA.
Table 1 Shows baseline characteristics of the patients
Number of patients 25
Age (years) 58±7
BMI (kg/m2) 28±4
Male (%) 19 (76)
Female (%) 6 (24)
Types of AF
Paroxysmal (%) 12 (48)
Persistent (%) 13 (52)
History of AF (months) 24 (14.8–50.3)
Prior antiarrhythmic drugs 1.2±0.7
Hypertension 20 (80)
Diabetes mellitus 2 (8)
Coronary artery disease 4 (16)
Echocardiography
Left atrial diameter (PLAX) 41±6
Left atrial volume (mL) 36.8±11.2
LVEF 54±6
PFO 3 (12)
CHA2DS2vasc score 1.5±1
HAS BLED score 1 (0–1)
EHRA score I/II/III/IV 2/18/5/0
Numbers are given as mean±standard deviation, as median and inter-
quartile range or as number and percentage
Table 2 Procedural data in our study patients
Procedural data
Number of procedures 25
PVI number 1.6±0.6
Procedure duration (min) 124 (103–151)
Fluoroscopy time (min) 8.9±6.7
Dose area product (μGym2) 1245 (659–1939)
Total ablation time (s) 1721.6±829.9
Complications 0
Recrossing data
Number of transseptals 2
Transseptal difficulty 1/2/3 19/3/3
Recrossing success total 50/50
Transseptal success EF 25/25
Transseptal success EO 25/25
Time for recrossing total (s) 14 (7–20)
Time for recrossing EF 14 (8–26.5)*
Time for recrossing EO 12 (6.5–17.5)*
Time for recrossing depending on difficulty
of TSP total (s)
Easy 13 (7.0–18.5)**
Medium and difficult 18 (13.8–49.5)**
Complications 0
Numbers are given as mean±standard deviation or as median and inter-
quartile range
*p=0.26 for recrossing times between experienced operator and fellow;
**p=0.328 between easy TSP and medium and difficult combined
264 J Interv Card Electrophysiol (2014) 41:261–266
During the PVI procedures, access to the LA can be lost
due to catheter/sheath slipping in the right atrium, especially
in inexperienced hands. On the other, hand complex ablations
for persistent AF include mapping of both left and right atria
for CFAEs and lines. In these cases, regaining LA access can
be time-consuming and increases procedure and fluoroscopy
duration. Reaccess to the left atrium can be achieved either by
attempting to advance the ablation catheter through the sep-
tum guided by fluoroscopy or to repeat the transseptal punc-
ture. Both of these techniques require fluoroscopy. Since PVI
is the procedure with the highest radiation doses in electro-
physiology [10] efforts should be made to reduce radiation
exposure. Reduction has already been achieved with the use
of electroanatomic mapping systems [12, 13], but additional
reduction should be a goal in every procedure.
Recently, Nguyen et al. [14] described recrossing of the
interatrial septum in five patients using a remote magnetic
navigation system and electroanatomic mapping system.
Transseptal recrossing was successfully performed in all pa-
tients with no complications.
We showed that the interatrial septum can be readily
recrossed without the use of fluoroscopy in all of our 25
patients. While creating the FAM of the TSP and the sheath
added less than a minute to the procedure, recrossing was
successfully accomplished in a median of 14 s and could be
easily learned by the fellows. The procedure could be per-
formed safely and no complications occurred due to the
recrossing procedure. This is an important aspect because in
contrast to the soft and floppy ablation catheters used during
PVI with magnetic navigation (e.g., Thermocool RMT), the
ablation catheters used in this study (Thermocool SF and
Smart Touch) are relatively stiff at the tip. Contact force
information may even be used to prevent the operator from
using extensive force when attempting to recross the interatrial
septum. However, this was not analyzed systematically in this
study.
5 Study limitations
A relatively small number of patients were included in our
study. Even though we have not experienced complications
using this method, a recent study done by Lehrmann et al. [15]
showed incidence of 1.5 % of interatrial septum dissection
(IASD) and/or perforation when a catheter probing or trans
patent foramen ovale (PFO) technique was used for
transseptal access. However, in our patient series, it was
feasible and safe to recross the interatrial septum in all patients
twice, by senior operators and fellows without any significant
difference in the time required to recross. Also, we included
patients with a first PVI procedure as well as repeat procedures
and also patients in whom there were difficulties with
transseptal puncture. Therefore, we can assume that this
procedure can be repeated in most patients undergoing PVI.
On the other hand, we performed all procedures with one of
the available electroanatomic mapping system and all abla-
tions (and recrossings) with the same catheter type. Further
evaluations are needed with different mapping systems and
ablation catheters. Although recrossing with a different map-
ping system has been described [14], it was performed with
remote a magnetic navigation system, and in a smaller number
of patients.
6 Conclusion
Adding a simple and fast electroanatomical reconstruction of
the transseptal access to the standard left atrial mapping pro-
cedure allows for easy and fluoroscopy-free recrossing of the
interatrial septum during atrial fibrillation ablation and further
reduces radiation exposure during PVI.
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